Functional comparison of antisense proteins of HTLV-1 and HTLV-2 in viral pathogenesis by Benoit Barbeau et al.
“fmicb-04-00226” — 2013/8/6 — 10:42 — page 1 — #1
REVIEW ARTICLE
published: 07 August 2013
doi: 10.3389/fmicb.2013.00226
Functional comparison of antisense proteins of HTLV-1 and
HTLV-2 in viral pathogenesis
Benoit Barbeau1, Jean-Marie Peloponese2,3 and Jean-Michel Mesnard2,3*
1 Département des sciences biologiques and Centre de recherche BioMed, Université du Québec à Montréal, Montréal, QC, Canada
2 Centre d’études d’agents Pathogènes et Biotechnologies pour la Santé, Université Montpellier 1, Montpellier, France
3 UMR5236, Centre d’études d’agents Pathogènes et Biotechnologies pour la Santé, Centre National de la Recherche Scientiﬁque, Montpellier, France
Edited by:
Françoise Bex, Université Libre
de Bruxelles, Belgium
Reviewed by:
Hidekatsu Iha, Oita University, Japan




Centre d’études d’agents Pathogènes
et Biotechnologies pour la Santé,
Centre National de la Recherche
Scientiﬁque, 1919 Route de Mende,
34293 Montpellier Cedex 5, France
e-mail: jean-michel.mesnard@
cpbs.cnrs.fr
The production of antisense transcripts from the 3′ long terminal repeat (LTR) in human
T-lymphotropic retroviruses has now been clearly demonstrated. After the identiﬁcation
of the antisense strand-encoded human T-lymphotropic virus type 1 (HTLV-1) bZIP (HBZ)
factor, we reported that HBZ could interact with CRE-binding protein (CREB) transcription
factors and consequently turn off the important activating potential of the viralTax protein on
HTLV-1 5′ LTR promoter activity.We have recently accumulated new results demonstrating
that antisense transcripts also exist in HTLV-2, -3, and -4. Furthermore, our data have
conﬁrmed the existence of encoded proteins from these antisense transcripts (termed
antisense proteins of HTLVs or APHs). APHs are also involved in the down-regulation of
Tax-dependent viral transcription. In this review, we will focus on the different molecular
mechanisms used by HBZ and APH-2 to control viral expression. While HBZ interacts
with CREB through its basic zipper domain, APH-2 binds to this cellular factor through
a ﬁve amino acid motif localized in its carboxyl terminus. Moreover, unlike APH-2, HBZ
possesses an N-terminal activation domain that also contributes to the inhibition of the
viral transcription by interacting with the KIX domain of p300/CBP. On the other hand,
HBZ was found to induce T cell proliferation while APH-2 was unable to promote such
proliferation. Interestingly, HTLV-2 has not been causally linked to human T cell leukemia,
while HTLV-1 is responsible for the development of the adult T cell leukemia/lymphoma.
We will further discuss the possible role played by antisense proteins in the establishment
of pathologies induced by viral infection.
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INTRODUCTION
The human T-lymphotropic virus type 1 (HTLV-1) was the ﬁrst
pathogenic retrovirus to be isolated in humans (Poiesz et al.,
1980; Miyoshi et al., 1981). This virus is the etiological agent of
adult T cell leukemia/lymphoma (ATLL) and HTLV-1-associated
myelopathy/tropical spastic paraparesis (HAM/TSP). Although an
important number of individuals are infected by HTLV-1, only
10% will eventually develop pathologies (Barbeau and Mesnard,
2007; Matsuoka and Jeang, 2007). Leukemic cells in ATLL are
mostly CD4+ T cells. One of the best studied associations between
HTLV-1 and oncogenesis is the viral Tax protein, as demonstrated
in primary T cells and various mouse models (Matsuoka and
Jeang, 2007). It likely results from the capacity of Tax to acti-
vatemultiple transcription factors and to induce genetic instability
(Mesnard and Devaux, 1999; Boxus et al., 2008). However, Tax is
often repressed in cells from ATLL patients (Takeda et al., 2004;
Satou et al., 2006). Selective pressure mediated by strong anti-
Tax immune response might justify the lack of Tax expression in
ATLL cells (Hanon et al., 2000; Enose-Akahata et al., 2012). HTLV-
2 is closely related to HTLV-1 and shares most viral genes such
as Tax and Rex but HTLV-2 is clinically distinct from HTLV-1
since it is not associated with any forms of leukemia (Feuer and
Green, 2005). However, HTLV-2 can efﬁciently immortalize and
transform T lymphocytes in vitro (Ye et al., 2003) and HTLV-2 Tax
can immortalize human CD4+ T cells at higher efﬁciency than
HTLV-1 Tax (Imai et al., 2012). Taken together, these data sug-
gest that Tax expression is not sufﬁcient for ATLL development
and is thus dispensable at least for the late stage of leukemoge-
nesis. Additional viral proteins obviously are thereby needed to
play such a role. Indeed, growing evidence indicate that antisense
transcripts produced from the 3′ long terminal repeat (LTR) of
the HTLV-1 proviral DNA might ﬁt such a role. These transcripts
are involved in the production of the HTLV-1 bZIP (HBZ) fac-
tor in infected cells (Cavanagh et al., 2006; Murata et al., 2006).
We have recently demonstrated that such antisense transcription
also exists in HTLV-2-infected cells and permits the synthesis of
the antisense protein of HTLV-2 (APH-2; Halin et al., 2009). This
review will discuss the role of antisense transcription and resulting
viral proteins in the development of pathologies associated with
HTLV infection.
ANTISENSE TRANSCRIPTS ARE PRODUCED FROM THE 3′ LTR
OF THE HTLV PROVIRAL DNA
HTLV-1 and HTLV-2 are complex retroviruses sharing a similar
genome structure with an approximate 70% nucleotide sequence
homology (Feuer and Green, 2005). Like all retroviruses, they
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harbor essential genes for their replication, which include gag, pol
and env. In addition to these genes, they harbor genes coding for
the Tax and Rex regulatory proteins (Figure 1). Tax acts in trans to
activate transcription initiating from the viral promoter in the 5′
LTR and Rex regulates viral gene expression post-transcriptionally
by facilitating cytoplasmic shuttling of incompletely spliced viral
mRNAs. HTLV-1 encodes the accessory proteins p12, p13, and p30
whereas HTLV-2 encodes the p10, p11, and p28 accessory gene
products (Figure 1). Studies have indicated that these proteins are
dispensable for in vitro infection and transformation of T cells but
are important for the ability of the virus to infect, spread, and per-
sist in vivo (Albrecht and Lairmore, 2002; Feuer and Green, 2005).
Transcription of all these viral genes is dependent on the 5′ LTR
region, which is segmented in three regions termed U3, R, and U5.
TheU3 region harbors important elements like the Tax-responsive
elements (TxREs). A Tax dimer interacts with cellular Activating
Transcription Factor/CRE-binding (ATF/CREB) proteins bound
speciﬁcally to TxREs (Basbous et al., 2003b; Nyborg et al., 2010).
The formation of such a complex on the 5′ LTR then serves as a
binding site for the recruitment of the pleiotropic cellular coactiva-
tors p300/CBP through their interaction with Tax. Recruitment of
p300/CBP to the viral promoter induces local nucleosome mod-
iﬁcation by histone acetylation and facilitates stable binding of
components of the basal transcription machinery allowing the
stimulation of viral transcription (Gachon et al., 2002; Luebben
et al., 2010).
For a long time, all retroviral genes have been thought to
be transcribed through the U3 region in the 5′ LTR of the
provirus. However, the production of antisense transcripts from
the 3′ LTR in HTLV-1-infected cell lines (Larocca et al., 1989)
and the presence of a conserved open reading frame (ORF) in
the complementary strand of the HTLV-1 provirus (Larocca et al.,
1989; Gaudray et al., 2002) suggested the existence of viral mRNA
of negative polarity. In 2002,we clearly demonstrated the existence
of an antisense strand-encoded protein termed HBZ in HTLV-
1-infected cell lines (Gaudray et al., 2002). Further experiments
by our teams and others have revealed that the antisense HBZ-
encoding transcript was spliced and polyadenylated (Cavanagh
et al., 2006; Murata et al., 2006; Satou et al., 2006; Yoshida et al.,
2008) and that different HBZ isoforms could be produced, with
one of them being the most abundant and dependent on a spliced
transcript (Figure 1). In 2009, we also characterized a spliced
antisense mRNA in HTLV-2-infected cell lines, involved in the
production of APH-2 (Halin et al., 2009). This transcript is struc-
tured similarly to the HBZ transcript, i.e., it is spliced, initiates in
the 3′ LTR at multiple sites, and is polyadenylated. The length of
the intron and of the 5′ and 3′ untranslated regions is also similar
to that of the HBZ transcript (Figure 1). These similarities could
suggest that the expression of antisense transcription in the HTLV
(and STLV) retrovirus family has been conserved among the dif-
ferent viruses. Indeed, we have recently conﬁrmed the synthesis of
antisense proteins from HTLV-3 and -4 proviral DNA (Larocque
et al., 2011). On the other hand, unlike HBZ mRNA, we did not
observe alternative splicing for APH-2, -3, and -4 mRNAs (Halin
et al., 2009; Larocque et al., 2011) suggesting that these retroviral
antisense genes are likely producing a single isoform.
HBZ AND APH-2 INHIBIT Tax-DEPENDENT VIRAL
TRANSCRIPTION
Initial studies highlighted the negative impact of HBZ expres-
sion on HTLV-1 replication by virtue of its capacity to inhibit
Tax-mediated activation of HTLV-1 transcription (Gaudray et al.,
FIGURE 1 | HTLV-1 and HTLV-2 proviral DNA. Viral ORFs are depicted as
either common retroviral proteins (blue), regulatory factors (red), or accessory
proteins (yellow). Antisense strand-encoded ORFs are also indicated (green).
Antisense transcripts are initiated from the 3′ LTR and spliced to produce the
antisense proteins, HBZ and APH-2. In both cases, transcripts are initiated at
a similar position in the 3′ LTR (which constitutes the ﬁrst exon) and are
spliced to the second exon, which contains the main ORF region as well as
the 3′ untranslated region. Their polyA tail is positioned 1450 nucleotides from
the ORF stop codon. In HTLV-1, an unspliced transcript initiating downstream
of the 3′ LTR (not shown here) has also been described (Yoshida et al., 2008).
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2002; Arnold et al., 2006). HBZ acts as a repressor of viral tran-
scription by forming heterodimers with CREB, CREB-2, CREM,
and ATF-1 that are no longer capable of binding to TxRE. HBZ
is a nuclear transcriptional factor able to interact with ATF/CREB
proteins (Gaudray et al., 2002; Lemasson et al., 2007; Hagiya et al.,
2011) through its basic zipper (bZIP) domain (Figure 2), lead-
ing to inhibition of their DNA-binding activity (Hivin et al.,
2005, 2006). Consequently, Tax cannot be positioned on the
viral promoter and is thereby unable to trans-activate HTLV-1
transcription (Gaudray et al., 2002; Lemasson et al., 2007). Inter-
estingly, APH-2 has also been shown to repress Tax-mediated viral
transcription (Halin et al., 2009; Yin et al., 2012) by interacting
with CREB. However, unlike HBZ, this interaction is mediated by
the LXXLL motif present in the C-terminus of APH-2 (Figure 2;
Yin et al., 2012). Interestingly, it has been shown that the repressive
activity of APH-2 is less strong than that of HBZ. This difference
in the inhibitory potential of both proteins might be explained by
the additional interaction of HBZ with p300/CBP. Unlike APH-
2, HBZ possesses a transcriptional activation domain within its
N-terminal region (Figure 2) involved in an interaction with the
KIX domain of p300/CBP (Clerc et al., 2008; Cook et al., 2011). In
the context of viral transcription, we have demonstrated that HBZ
could displace p300/CBP from the HTLV-1 promoter by compet-
ing with Tax for binding to the KIX domain (Clerc et al., 2008).
Moreover, this mechanism appears more efﬁcient than that of
the ZIP domain in mediating repression of Tax-dependent viral
transcription. On the other hand, additional reports have demon-
strated that HBZ can activate cellular gene transcription through
its interaction with p300/CBP (Kuhlmann et al., 2007; Polakowski
et al., 2010; Macaire et al., 2012).
Analyses of transcription factors involved in the regulation of
HTLV-1 antisense transcription showed that the Sp1 transcription
factor was critical for its trans-activation (Yoshida et al., 2008;
Gazon et al., 2012). We recently demonstrated that Sp1 enhanced
antisense transcription by cooperating with the HBZ–JunD het-
erodimer (Gazon et al., 2012), which implicates the previously
reported ZIP-dependent interaction between HBZ and JunD
(Thébault et al., 2004; Figure 2). Thus, HBZ not only inhibits
expression of other viral proteins such as Tax but also stimulates
its own expression. While the majority of HTLV-1-speciﬁc CD8+
T cells recognize the Tax protein, the frequency of HBZ-speciﬁc
CD8+ T cells is signiﬁcantly lower (Macnamara et al., 2010).
HBZ-expressing cells could thus escape lysis from a cytotoxic
T lymphocyte (CTL) response and would consequently enhance
viral persistence in infected people (Suemori et al., 2009; Macna-
mara et al., 2010). It has also been suggested that Tax can stimulate
HBZ expression although this issue remains controversial, as most
results were obtained from cell lines transfected with a Tax expres-
sion plasmid and reporter vectors containing only one HTLV-1
LTR(Larocca et al., 1989; Cavanagh et al., 2006;Yoshida et al., 2008;
Landry et al., 2009). Indeed, such an effect byTax has not been con-
ﬁrmed inT cells infectedwith a complete proviral DNA containing
two LTRs (Belrose et al., 2011). Moreover, we have observed that
activation of sense transcription from the 5′ LTR down-regulated
the synthesis of antisense transcripts from the 3′ LTR (Cavanagh
et al., 2006; Landry et al., 2007). It should also be emphasized
that the regulation of APH-2 expression in infected cells remains
currently unknown.
HBZ AND APH-2 REGULATE THE AP-1 PATHWAY IN A
DIFFERENT MANNER
In unstimulated T cells, basal protein levels of the AP-1 complex
are low but there is a rapid induction of AP-1 activity after T cell
stimulation. The AP-1 transcription complex has been shown to
FIGURE 2 | Schematic representations of HBZ andAPH-2 functional
domains. Both proteins contain basic domains (blue) involved in their nuclear
localization. HBZ possesses an N-terminal activation domain (AD in red),
a modulatory domain (MD in yellow) and a ZIP (green) controlling the
transcriptional activity of Jun and ATF/CREB proteins.While APH-2 does not
contain any activation domain, it can interact with c-Jun and JunB through a
non-canonical ZIP region (ncZIP in green) and with CREB through a C-terminal
CREB-binding motif (CBM in black). Unlike HBZ, APH-2 binds to Tax (+) and
(−) respectively indicate an activating or inhibiting effect of viral proteins on
targeted proteins.
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be involved in the regulation of numerous cellular genes involved
in lymphocyte activation. The AP-1 transcription factor consists
of heterodimers between the Jun (c-Jun, JunB, and JunD) and Fos
(c-Fos, FosB, Fra-1, and Fra-2) family members through their
ZIP domains. AP-1 complexes are not limited to Jun and Fos
dimers, since Jun and Fos proteins have been shown to dimerize
with other bZIP proteins, including members of the ATF/CREB
family and the Maf transcription factors. ATLL cells have been
shown to contain constitutively activated AP-1 complexes, which
are mainly constituted of JunD (Mori et al., 2000). HBZ, via its
ZIP domain, forms heterodimers with all the members of the Jun
family (Basbous et al., 2003a; Thébault et al., 2004). The interac-
tion of HBZ with c-Jun and JunB results in repression of their
transcriptional activity through degradation or sequestration into
transcriptionally inactive nuclear bodies (Basbous et al., 2003a;
Matsumoto et al., 2005; Hivin et al., 2007; Clerc et al., 2009). On
the other hand, the HBZ/JunD heterodimer can activate tran-
scription of cellular genes such as the human telomerase catalytic
subunit (hTERT) and the antiapoptotic Bﬂ-1 (Kuhlmann et al.,
2007; Macaire et al., 2012). HBZ can also dysregulate other cell-
signaling pathways such as FoxP3 (Satou et al., 2011),NF-κB (Zhao
et al., 2009; Zhi et al., 2011; Wurm et al., 2012), TGF-β (Zhao
et al., 2011), and Wnt pathways (Ma et al., 2012). The resulting
dysregulated pathways suggest that HBZ expression might play a
central role in the development of ATLL and HAM/TSP through
these altered transcription factors (Mesnard et al., 2006; Satou
et al., 2006, 2011; Arnold et al., 2008; Zhi et al., 2011; Sugata et al.,
2012).
Unlike HBZ, analysis of APH-2 does not predict a typical
bZIP domain. However, APH-2 does interact with c-Jun and
JunB through its non-canonical bZIP domain (Figure 2; Mar-
ban et al., 2012). Although inconsistently, APH-2 does not appear
to bind to JunD in vivo (Marban et al., 2012). However, given
the unique structure of its ZIP domain it is not surprising that
APH-2 does not form canonical interactions with human bZIPs
(Reinke et al., 2010). An interesting outcome from the interac-
tion between APH-2 and the different Jun family members is that
APH-2 potentiates their trans-activation activity (Marban et al.,
2012). This is thereby in sharp contrast to the negative or pos-
itive modulation of HBZ on the various Jun factors. Interesting
results from this study have also inferred a potential complex
between Tax2B and APH-2 involving a region from amino acid
102 to 183. As no competition occurred between Jun factors
and Tax2B in their binding to APH-2, the region of interac-
tion for Tax2B is likely located outside the bZIP-like domain
(Figure 2). Furthermore, the modulation of AP-1 activation by
Tax2B was greatly reduced when APH-2 was co-expressed. How-
ever, the above experiments were conducted in overexpression
condition and it will therefore be mandatory to conﬁrm these
data with physiologically relevant expression levels. These results
highlight a very complex interplay between Tax 2 and APH-2 in
relation to other transcription factors and it will be important
to determine how this type of interaction is affected in the con-
text of ATF/CREB family members. Furthermore, we have not
observed that HBZ interacts with Tax (Hivin et al., 2005) and
therefore further experiments will be required to address this
issue.
HBZ INDUCES IL-2-INDEPENDENT T CELL PROLIFERATION
Based on the effect of HBZ on AP-1-dependent gene expression,
HBZ might contribute to the dysregulation of cell proliferation
in infected cells. In fact, two reports using HBZ-speciﬁc shRNA
expression vectors have demonstrated that HBZ was important
for the proliferation of HTLV-1-infected cell lines (Satou et al.,
2006; Arnold et al., 2008). In these studies, although HBZ was
not found to be required for HTLV-1-induced peripheral blood
mononuclear cell (PBMC) immortalization,HBZwas shown to be
important for cell proliferation of infected cells and had an impact
in infection experiments in rabbits. Furthermore, along with these
studies, other reports have determined that HBZ expression corre-
lated with proviral DNA load, likely through its capacity to permit
infected cells to proliferate (Arnold et al., 2008; Li et al., 2009).
Basedon these reports,HBZhas further been associatedwithATLL
development. Early implication of HBZ in ATLL development has
been based on the occurrence of HBZ expression in ATLL cells
from most tested patients (Satou et al., 2006; Usui et al., 2008).
This is in contrast to Tax, whose expression is often repressed
in ATLL cells. A balance between Tax and HBZ expression (Bar-
beau and Mesnard, 2011) might thereby be important to permit
cells to proliferate and, in fact might be determinant in hamper-
ing previously reported Tax-mediated cell senescence (Zhi et al.,
2011). More recent evidence has also permitted to suggest mech-
anisms by which HBZ could be implicated in ATLL, such as its
induction of hTERT expression via a Sp1-dependent mechanism
(Kuhlmann et al., 2007), its interaction with ATF-3 to suppress
the ATF-3-induced p53 transcription activity stimulation (Hagiya
et al., 2011), and the inhibition of p300/CBP acetyl transferase
activity (Wurmet al., 2012). Additional data also argue for a poten-
tial oncogenic property of HBZ. Indeed, experiments in transgenic
mice expressing HBZ in CD4+ T cells resulted in high incidence of
T cell lymphoma (Satou et al., 2011). In addition,NOD/SCIDmice
engrafted with HBZ-silenced HTLV-1-infected cells were less inﬁl-
trating and formed tumors at lesser extent than control infected
cells (Arnold et al., 2008). We have also recently demonstrated that
proviral DNA-expressed HBZ induced anchorage-independent
growth in NIH 3T3 cells and correlated with induced JunD expres-
sion (Gazon et al., 2012). An intriguing observation also suggests
that the HBZ transcript itself could be essential for induced IL-
2-independent T cell proliferation (Satou et al., 2006). Kinetics
and intracellular compartmentalization study of HTLV-1 mRNA
expression is indirectly favoring the implication of such a tran-
script in cell proliferation, as HBZ viral transcripts have been
shown strongly sequestered in thenucleuswhen compared toother
viral transcripts (Rende et al., 2011). However, these data have
been obtained after transfection of HLtat cells with the HTLV-1
proviral clone ACH. When 293T cells were similarly transfected,
such a nuclear retention of HBZ mRNA was not conﬁrmed (Li
et al., 2012) showing that this observation strongly depends on
the transfected cell line and has to be conﬁrmed in physiologically
relevant conditions.
Recent studies have compared the proliferation-inducing
capacity of APH-2 to this functional characteristic of HBZ
(Douceron et al., 2012). Although not associatedwith any forms of
leukemia, HTLV-2 has nonetheless been linked to lymphocytosis
in infected patients (Bartman et al., 2008). Certain similar features,
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reminiscent of a potential impact on cell proliferation, were noted
when similar analyses were performed on APH-2. First, APH-2
expression has been detected in most PBMC samples of HTLV-2-
infectedpatients (Halin et al.,2009;Douceron et al.,2012). Second,
a correlation between APH-2 expression levels and proviral DNA
load was also noted (Douceron et al., 2012). Furthermore, a typi-
cal nuclear sequestration of its mRNA was inferred in both patient
cells and infected cell lines (Bender et al., 2012). However, unlike
HBZ,APH-2 is not capable of leading to IL-2-independent growth
of IL-2-dependent cell lines (Douceron et al., 2012). Moreover, the
absence of an impact on proliferation was further suggested in a
study demonstrating no impact on proliferation of infected cells
lines in addition to no effect on the immortalization capacity of
HTLV-2 on infected PBMCs (Yin et al., 2012). In conclusion, no
clear correlation between APH-2 mRNA expression, its nuclear
retention, and HTLV-2-induced lymphocytosis was observed.
PERSISTENCE OF HTLV-1 VS. HTLV-2 INFECTION IN RELATION
TO THEIR RESPECTIVE ANTISENSE PROTEIN
Using the rabbit model, a number of elegant studies have focussed
on the consequence of HBZ silencing on HTLV-1 replication.
Although no drastic differences were noted in HTLV-1 infection
and replication in cell culture conditions, infection of rabbits with
irradiated HTLV-1-producing cells highlighted an important role
of HBZ on HTLV-1 persistence, as indicated by anti-HTLV-1 anti-
body titers and proviral DNA loads (Arnold et al., 2006). When
similar experiments were conducted with HTLV-2, again APH-2
did not alter viral replication in cell culture experiments. How-
ever, inoculation of rabbit with irradiated cells producing HTLV-2
virions deﬁcient for APH-2 led to a higher and more sustained
antibody response correlating with higher proviral load at cer-
tain time points (Yin et al., 2012). These results thereby argue
that, unlike HBZ, APH-2 is not necessary for viral persistence
but might instead be related to the reduced capacity of HTLV-2
infection.
Both HTLV-1 and HTLV-2 are able to establish a persis-
tent infection in CD4+ and CD8+ T cells but HTLV-1 estab-
lishes a more robust infection in T lymphocytes (Kannian et al.,
2012). Moreover, infection results in an increase in provi-
ral loads and viral expression such as Tax, Gag, and Env
(Figure 3). However, cells highly expressing viral proteins are
eliminated by the humoral response and CTL activity of the host
FIGURE 3 | HBZ andAPH-2 differently impactT cell proliferation. Infection
of T lymphocytes with HTLV-1 or HTLV-2 results in an increase in proviral
loads, with a more pronounced effect for HTLV-1 proviral DNA load. An
antibody response against Gag and Env andTax-speciﬁc CTL responses
induces killing of infected cells. HTLV-1 can evade the immune response by
reducingTax and stimulating HBZ expression. HBZ would subsequently
promote the establishment of a chronic infection by inhibiting Tax-dependent
viral transcription, stimulating its own expression, and inducingT cell
proliferation. APH-2 also down-regulates Tax-dependent HTLV-2 transcription
but is unable to induce cell proliferation. A low expression of Tax induced by
APH-2 through its capacity to positively modulate c-Jun activation could be
responsible for HTLV-2-stimulated lymphocytosis.
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(Macnamara et al., 2010; Enose-Akahata et al., 2012; Enose-
Akahata et al., 2013). At this stage, HBZ and APH-2 might
play a crucial role by down-regulating Tax-dependent viral tran-
scription and may allow infected cells to evade the immune
response. In additionally, HBZ promotes the proliferation of
infected T lymphocytes (Figure 3). This dual action probably
confers a survival advantage on HBZ-expressing cells and is con-
sistent with the observation that HBZ favors the establishment of
persistent infection in HTLV-1-inoculated rabbits (Arnold et al.,
2006). On the other hand, unlike HBZ, APH-2 is not required
for viral persistence (Yin et al., 2012) and unable to promote
lymphocytosis (Douceron et al., 2012). However, a low expres-
sion of Tax from the TxREs of the 5′ LTR induced by AP-1
transcriptional activity stimulated by APH-2 could explain lym-
phocytosis commonly observed in HTLV-2 carriers (Figure 3).
Further experiments are deﬁnitely needed to better under-
stand the mechanism by which HTLV-2 infection could lead to
lymphocytosis.
CONCLUSIONS AND PERSPECTIVES
The discovery of HBZ has led to important new research avenues
with potential association with HTLV-1-associated diseases. In
fact, ATLL cells from infected patients consistently express HBZ
and substantial evidence points toward its implication in viral per-
sistence and ATLL cell survival. Recent evidences further suggest
that HBZ lead toward a Treg phenotype. Future experiments will
be needed to determine if similar attributes can be given toAPH-2.
As HBZ and APH-2 also differ mechanistically and functionally in
their interaction with transcription factors such as Jun and CREB,
it will be important to further expand on these differences and
deﬁne the exact nature of these interactions. Several transcription
factors known to interact with HBZ will also need to be analyzed
in the context of APH-2 and in relation to the different cellu-
lar localizations of these proteins. In addition, the role played by
HBZ on proliferation needs to be clariﬁed as to how its transcript
impacts IL-2-independent growth. These studies might also con-
sider variation in the sequence of APH-2 transcripts, which could
explain their different ability in inducing proliferation. Finally,
these experiments should also be undertaken with equivalent anti-
sense proteins of HTLV-3 and HTLV-4, i.e., APH-3 and APH-4 to
determine how these proteins alter the various functions associ-
ated toHBZ. Finally, these comparative studieswill provide abetter
understanding as to the mechanism by which HBZ is involved in
ATLL development, which might also lead to new potential ATLL
treatment.
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